Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure

Abstract

These results are consistent with the use of buprenorphine as an acceptable treatment for opioid dependence in pregnant women. (Funded by the National Institute on Drug Abuse; ClinicalTrials.gov number, NCT00271219.).